Manufacturer of Controlled Substances; Notice of Registration, 77063-77064 [E6-21878]

Download as PDF 77063 Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices with the public interest at this time. DEA has investigated American Radiolabeled Chemicals, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21879 Filed 12–21–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated July 26, 2006, and published in the Federal Register on August 14, 2006, (71 FR 46514–46515), Applied Science Labs, Division of Alltech Associates Inc., 2701 Carolean Industrial Drive, State College, Pennsylvania 16801, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: jlentini on PROD1PC65 with NOTICES Drug Schedule Methcathinone (1237) .................. N–Ethylamphetamine (1475) ........ N,N–Dimethylamphetamine (1480). 4–Methylaminorex (cis isomer) (1590). Alpha–Ethyltryptamine (7249) ...... Lysergic acid diethylamide (7315) 2,5–dimethoxy–4–(n)– propylthiophenethylamine (2C– T–7) (7348). Tetrahydrocannabinols (7370) ..... Mescaline (7381) .......................... 4–Bromo–2,5– dimethoxyamphetamine (7391). 4–Bromo–2,5– dimethoxyphenethylamine (7392). 4–Methyl–2,5– dimethoxyamphetamine (7395). 2,5–Dimethoxyamphetamine (7396). 2,5–Dimethoxy–4– ethylamphetamine (7399). VerDate Aug<31>2005 19:31 Dec 21, 2006 I I I I I I I I I I I I I I Jkt 211001 Drug Schedule 3,4–Methylenedioxyamphetamine (7400). N–Hydroxy–3,4– methylenedioxyamphetamine (7402). 3,4–Methylenedioxy–N– ethylamphetamine (7404). 3,4– Methylenedioxymethamphetamine (7405). 4–Methoxyamphetamine (7411) ... Alpha–methyltryptamine (AMT) (7432). Bufotenine (7433) ......................... Diethyltryptamine (7434) .............. Dimethyltryptamine (7435) ........... Psilocybin (7437) .......................... Psilocyn (7438) ............................. 5–methoxy–N–,N– diisopropyltryptamine(5–MeO– DIPT) (7439). N–Ethyl–1– phenylcyclohexylamine (7455). 1–(1–Phenylcyclohexyl)pyrrolidine (PCPy) (7458). 1–[1–(2– Thienyl)cyclohexyl]piperidine (7470). Dihydromorphine (9145) ............... Normorphine (9313) ..................... Methamphetamine (1105) ............ 1–Phenylcylohexylamine (7460) .. Phencyclidine (7471) .................... Phenylacetone (8501) .................. 1–Piperidinocyclohexanecarbonitrile (8603). Cocaine (9041) ............................. Codeine (9050) ............................. Dihydrocodeine (9120) ................. Benzoylecgonine (9180) ............... Ethylmorphine (9190) ................... Meperidine intermediate–B (9233) Morphine (9300) ........................... Noroxymorphone (9668) .............. I I I I Frm 00104 Fmt 4703 Sfmt 4703 Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21875 Filed 12–21–06; 8:45 am] BILLING CODE 4410–09–P I I I I I I I I I I I I I II II II II II II II II II II II II II The company plans to manufacture high purity drug standards used for analytical application only in clinical, toxicological and forensic laboratories. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Applied Science Labs, Division of Alltech Associates Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Applied Science Labs, Division of Alltech Associates Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with State and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted PO 00000 registration as a bulk manufacturer of the basic classes of controlled substances listed. DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48945–48946), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule I and II: Drug N-Ethylamphetamine (1475) ........ Tetrahydrocannabinols (7370) ..... 2,5-Dimethoxyamphetamine (7396). 3,4-Methylenedioxyamphetamine (7400). 4-Methoxyamphetamine (7411) ... Amphetamine (1100) .................... Methamphetamine (1105) ............ Methylphenidate (1724) ................ Pentobarbital (2270) ..................... Phenylacetone (8501) .................. Hydromorphone (9150) ................ Hydrocodone (9193) ..................... Methadone (9250) ........................ Methadone Intermediate (9254) ... Morphine (9300) ........................... Sufentanil (9740) .......................... Fentanyl (9801) ............................ Schedule I I I I I II II II II II II II II II II II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex North Brunswick, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambrex North Brunswick, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification E:\FR\FM\22DEN1.SGM 22DEN1 77064 Federal Register / Vol. 71, No. 246 / Friday, December 22, 2006 / Notices of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21882 Filed 12–21–06; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21878 Filed 12–21–06; 8:45 am] DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P By Notice dated August 15, 2006, and published in the Federal Register on August 22, 2006, (71 FR 48946), Chemic Laboratories, Inc., 480 Neponset Street, Building 7C, Canton, Massachusetts 02021, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of Cocaine (9041), a basic class of controlled substance listed in schedule II. The company plans to manufacture small quantities of a cocaine derivative for distribution to its customers for the purpose of research. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Chemic Laboratories, Inc. to manufacture the listed basic class of controlled substance is consistent with the public interest at this time. DEA has investigated Chemic Laboratories, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic class of controlled substance listed. By Notice dated July 26, 2006, and published in the Federal Register on August 2, 2006, (71 FR 43813–43814), Clariant LSM (Missouri) Inc., 2460 W. Bennett Street, or (P.O. Box 1246, zip 65801), Springfield, Missouri 65807, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: DEPARTMENT OF JUSTICE Drug Enforcement Administration jlentini on PROD1PC65 with NOTICES Importer of Controlled Substances Notice of Registration By Notice dated August 15, 2006 and published in the Federal Register on August 22, 2006, (71 FR 48946), Cambrex North Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, North Brunswick, New Jersey 08902, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Phenylacetone (8501), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance to manufacture amphetamine. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and § 952(a) and determined that the registration of Cambrex North Brunswick, Inc. to import the basic class of controlled substance is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Cambrex North Brunswick, Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 952(a) and § 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed. VerDate Aug<31>2005 17:45 Dec 21, 2006 Jkt 211001 Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21881 Filed 12–21–06; 8:45 am] BILLING CODE 4410–09–P PO 00000 Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration Drug Methylphenidate (1724) ................ Phenylacetone (8501) .................. Methadone intermediate (9254) ... Schedule II II II The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Clariant LSM (Missouri) Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Clariant LSM (Missouri) Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: December 14, 2006. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E6–21876 Filed 12–21–06; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration Manufacturer of Controlled Substances Notice of Registration By Notice dated August 7, 2006, and published in the Federal Register on Frm 00105 Fmt 4703 Sfmt 4703 E:\FR\FM\22DEN1.SGM 22DEN1

Agencies

[Federal Register Volume 71, Number 246 (Friday, December 22, 2006)]
[Notices]
[Pages 77063-77064]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-21878]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated August 15, 2006, and published in the Federal 
Register on August 22, 2006, (71 FR 48945-48946), Cambrex North 
Brunswick, Inc., Technology Centre of New Jersey, 661 Highway One, 
North Brunswick, New Jersey 08902, made application by renewal to the 
Drug Enforcement Administration (DEA) to be registered as a bulk 
manufacturer of the basic classes of controlled substances listed in 
schedule I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
N-Ethylamphetamine (1475)..................  I
Tetrahydrocannabinols (7370)...............  I
2,5-Dimethoxyamphetamine (7396)............  I
3,4-Methylenedioxyamphetamine (7400).......  I
4-Methoxyamphetamine (7411)................  I
Amphetamine (1100).........................  II
Methamphetamine (1105).....................  II
Methylphenidate (1724).....................  II
Pentobarbital (2270).......................  II
Phenylacetone (8501).......................  II
Hydromorphone (9150).......................  II
Hydrocodone (9193).........................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Morphine (9300)............................  II
Sufentanil (9740)..........................  II
Fentanyl (9801)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Cambrex North Brunswick, Inc. to manufacture the listed basic classes 
of controlled substances is consistent with the public interest at this 
time. DEA has investigated Cambrex North Brunswick, Inc. to ensure that 
the company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification

[[Page 77064]]

of the company's compliance with state and local laws, and a review of 
the company's background and history. Therefore, pursuant to 21 U.S.C. 
823, and in accordance with 21 CFR 1301.33, the above named company is 
granted registration as a bulk manufacturer of the basic classes of 
controlled substances listed.

    Dated: December 14, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E6-21878 Filed 12-21-06; 8:45 am]
BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.